Healthcare Improvement Scotland has published a case study provided by Crohn’s & Colitis UK, highlighting the benefits of effective patient group engagement in the drug approval process.
The Scottish Medicines Consortium (SMC) also recently referenced the blog post in highlighting the value of ‘nuggets of reality’.
Health Service Project Manager for Crohn’s & Colitis UK, Nancy Greig, commented that:
‘For me, what made a good patient group submission are the ‘nuggets’ of reality that we and those we support can provide.’
Greig also highlighted the role of patient groups to ensure that the SMC considers the difference potential treatments could have on patient lives.
Our role as a patient group is to ensure SMC Committee members consider the difference that potential treatments may make to the lives of people with Crohn’s and Colitis and their carers. Medicines are vital to managing and treating the symptoms of Crohn’s and Colitis, as well as extra-intestinal symptoms and complications.
For further information, find Healthcare Improvement Scotland blog article here.